Clinical Trials
30 trialsNCT00001595 2026-05-22
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
National Institutes of Health Clinical Center (CC)
Recruiting
NCT00461188 2026-05-20
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Barts & The London NHS Trust
Recruiting
NCT03665064 2026-03-16
Long Term Outcome Study in Patients With Pituitary Disorders
University of Alberta
Active not recruiting
NCT07306325 2025-12-29
Ultrasound in Predicting Difficult Intubation in Acromegaly Patients
Başakşehir Çam & Sakura City Hospital
Not yet recruiting
NCT05364944 2025-11-17
OXTEND-01
Debiopharm International SA
Phase 1 Terminated
NCT07179926 2025-09-18
Pasi-Bone
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT01809808 2025-08-26
A Prospective Study of Outcome After Therapy for Acromegaly
Columbia University
Completed
NCT06253897 2024-12-24
BackSOM
Ipsen
Completed
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT06326853 2024-06-11
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
IRCCS San Raffaele
Not yet recruiting
NCT02419664 2022-03-31
Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Göteborg University
Phase 3 Terminated
NCT01861717 2021-09-30
A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.
Saint John's Cancer Institute
Phase 4 Terminated
NCT00446082 2020-12-21
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Novartis
Phase 1 Completed
NCT00001981 2020-11-27
The Treatment and Natural History of Acromegaly
National Institutes of Health Clinical Center (CC)
Completed
NCT04529356 2020-08-27
The TMS Treatment for Postoperative Headache in GH Tumor
Huashan Hospital
Phase NA Unknown
NCT03474601 2020-03-18
SNU-PIT
Seoul National University Hospital
Unknown
NCT02354508 2019-12-10
Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
Novartis
Phase 3 Completed
NCT01673646 2019-09-16
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism
Novartis
Phase 2 Completed
NCT01840449 2019-01-14
SOPRANo
Ipsen
Completed
NCT01504399 2018-08-22
Rhinological Outcomes in Endonasal Pituitary Surgery
St. Joseph's Hospital and Medical Center, Phoenix
Completed
NCT01137682 2018-04-05
PAOLA
Novartis
Phase 3 Completed
NCT03439709 2018-03-01
MERGE
Samsung Medical Center
Phase 3 Unknown
NCT02299089 2017-12-15
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
Camurus AB
Phase 2 Completed
NCT00376064 2017-03-06
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
Phase 4 Completed
NCT02854228 2016-08-03
PITUICARE-Lyon
Hospices Civils de Lyon
Unknown
NCT01029275 2014-07-31
SAPORO
University Hospital, Rouen
Phase NA Completed
NCT01368133 2013-09-26
The Observational Study of Growth Hormone-secreting Pituitary Tumors
Huashan Hospital
Unknown
NCT00598949 2010-12-15
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Cedars-Sinai Medical Center
Unknown
NCT00001860 2008-03-04
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00461149 2007-04-17
HDacro
Federico II University
Phase 4 Completed